portfolio detail ImStem Biotechnology

ImStem Biotechnology

About:
ImStem Biotechnology is a company focused on developing cell therapeutic products derived from human pluripotent stem cells (hESC or iPSC) for tissue repair, treatment of neural, heart, vascular and blood system diseases and autoimmune diseases.

Website:
www.imstem.com

CI Representative:
Daniel Wagner
Managing Director, Investments

back to portfolio